Article Sidebar

PDF
Date Published: 30/01/2024
Abstract Views: 320
Views PDF: 430
DOI: https://doi.org/10.51298/vmj.v534i1B.8274
Issue
Vol. 534 No. 1B (2024)
Section
Các bài báo
How to Cite
Trần , T. C. N. ., Trần , T. H. N. ., Lê, Đặng T. N. ., Trần , N. T. P. ., Phạm , T. T. H. ., Lê, Đình T. ., Nguyễn, T. Q. N., & Nguyễn, T. H. Y. . (2024). SYSTEMATIC REVIEW ON QUESTIONNAIRE TO ASSESS THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC KIDNEY DISEASE. Vietnam Medical Journal, 534(1B). https://doi.org/10.51298/vmj.v534i1B.8274

SYSTEMATIC REVIEW ON QUESTIONNAIRE TO ASSESS THE QUALITY OF LIFE OF PATIENTS WITH CHRONIC KIDNEY DISEASE

Thị Cao Nguyên Trần , Thị Hồng Nguyên Trần , Đặng Tú Nguyên Lê, Ngọc Thiên Phú Trần , Thị Thu Hiền Phạm , Đình Thanh Lê, Thị Quỳnh Nga Nguyễn, Thị Hải Yến Nguyễn

Main Article Content

Abstract

Background: To improve the management and treatment of patients with chronic kidney disease (CKD), there is a need for a set of quality of life questionaire to identify the problems and difficulties that patients are facing and monitor the effectiveness of treatment. Subjects and Methods: Systematic review of quality of life instrument for CKD in the period 2012-2022 on Pubmed, Cochrane and ScienceDirect databases. Results: From 3 databases, the study synthesized 4241 non-overlapping studies. Then, through the selection process, 30 studies were selected for inclusion in the systematic review. Among the 16 quality of life questionaires, KDQOL-36 has been widely studied on many subjects with chronic kidney disease. Evaluation results show that the KDQOL-36 questionnaire has a lot of evidence to ensure the internal consistency, reliability and structural validity of the questionnaire. Conclusion: KDQOL-36 is a valid and reliable questionnaire, suitable for the goal of measuring QOL in many subjects with chronic kidney disease.

Article Details

References

1. Kovesdy CPJKIS. Epidemiology of chronic kidney disease: an update 2022. 2022;12(1):7-11.
2. Bajema KL, Dahl RM, Evener SL, Prill MM, Rodriguez-Barradas MC, Marconi VC, et al. Comparative effectiveness and antibody responses to moderna and Pfizer-BioNTech COVID-19 vaccines among hospitalized veterans—five Veterans Affairs Medical Centers, United States, February 1–September 30, 2021. 2021;70(49):1700.
3. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Revista espanola de cardiologia (English ed). 2021;74(9):790-9.
4. Mokkink LB, Terwee CB, de Vet HC. COSMIN: Consensus-based standards for the selection of health status measurement instruments. Encyclopedia of quality of life and well-being research: Springer; 2021. p. 1-4.
5. Mokkink LJAPHRIA, The Netherlands. COSMIN Risk of Bias checklist. 2018.
6. RAND Health Care. Kidney Disease Quality of Life Instrument (KDQOL): https://www.rand.org/ health-care/surveys_tools/kdqol.html; [
7. Aiyegbusi OL, Kyte D, Cockwell P, Marshall T, Gheorghe A, Keeley T, et al. Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic review. PLoS One. 2017;12(6):e0179733.